health π¬ HIV fight: long-acting tools help while vaccine search continues
Researchers reviewed various non-vaccine strategies to combat HIV transmission, noting the difficulty in developing an effective vaccine. Strategies like long-acting injectables and gene-editing offer potential pathways toward the 2030 AIDS goal. For instance, lenacapavir showed 100% and 96% prevention efficacy in Phase III trials with every six-month injections. Long-acting cabotegravir also showed significant reduction in HIV acquisition compared to daily oral treatment. These tools, alongside U=U and VMMC, are key parts of the current prevention landscape. π¬